Asuka Katsuki

2.0k total citations
82 papers, 1.4k citations indexed

About

Asuka Katsuki is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Asuka Katsuki has authored 82 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cellular and Molecular Neuroscience, 26 papers in Cognitive Neuroscience and 24 papers in Psychiatry and Mental health. Recurrent topics in Asuka Katsuki's work include Treatment of Major Depression (18 papers), Schizophrenia research and treatment (17 papers) and Functional Brain Connectivity Studies (17 papers). Asuka Katsuki is often cited by papers focused on Treatment of Major Depression (18 papers), Schizophrenia research and treatment (17 papers) and Functional Brain Connectivity Studies (17 papers). Asuka Katsuki collaborates with scholars based in Japan, United States and China. Asuka Katsuki's co-authors include Reiji Yoshimura, Hikaru Hori, Jun Nakamura, Kiyokazu Atake, Atsuko Ikenouchi, Wakako Umene‐Nakano, Kenji Hayashi, Shingo Kakeda, Yukunori Korogi and Keita Watanabe and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Asuka Katsuki

82 papers receiving 1.4k citations

Peers

Countries citing papers authored by Asuka Katsuki

Since Specialization

Citations

This map shows the geographic impact of Asuka Katsuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asuka Katsuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asuka Katsuki more than expected).

Fields of papers citing papers by Asuka Katsuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asuka Katsuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asuka Katsuki. The network helps show where Asuka Katsuki may publish in the future.

Co-authorship network of co-authors of Asuka Katsuki

This figure shows the co-authorship network connecting the top 25 collaborators of Asuka Katsuki. A scholar is included among the top collaborators of Asuka Katsuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asuka Katsuki. Asuka Katsuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of the number of hospitalizations on cognitive function in Japanese patients with stable schizophrenia 2020 ·CNS Spectrums ·Hikaru Hori, Kiyokazu Atake, Asuka Katsuki, Reiji Yoshimura	9
2	Pharmacological management of bipolar disorder: Japanese expert consensus 2020 ·Bipolar Disorders ·Hitoshi Sakurai, Masaki Kato, Norio Yasui‐Furukori, Takefumi Suzuki, Hajime Baba, Koichiro Watanabe, Ken Inada, Ikuko Kishida, Yuka Kikuchi, Toshiaki Kikuchi, Asuka Katsuki, Hiroyuki Uchida	14
3	The brain-derived neurotrophic factor Val66Met polymorphism increases segregation of structural correlation networks in healthy adult brains 2020 ·PeerJ ·Issei Ueda, Kazuhiro Takemoto, Keita Watanabe, Koichiro Sugimoto, Atsuko Ikenouchi, Shingo Kakeda, Asuka Katsuki, Reiji Yoshimura, Yukunori Korogi	5
4	Risk factors for further sick leave among Japanese workers returning to work after an episode of major depressive disorder: a prospective follow-up study over 1 year 2019 ·BMJ Open ·Hikaru Hori, Asuka Katsuki, Kiyokazu Atake, Reiji Yoshimura, Jun Nakamura, Bernhard T. Baune	13
5	<p>A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder</p> 2019 ·Neuropsychiatric Disease and Treatment ·Asuka Katsuki, Shingo Kakeda, Keita Watanabe, Ryohei Igata, Yuka Otsuka, Taro Kishi, (unknown), Issei Ueda, Nakao Iwata, Yukunori Korogi, Reiji Yoshimura	11
6	<p>Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms</p> 2019 ·Neuropsychiatric Disease and Treatment ·Shingo Kakeda, Keita Watanabe, Asuka Katsuki, Koichiro Sugimoto, Issei Ueda, (unknown), Taro Kishi, Nakao Iwata, Osamu Abe, Reiji Yoshimura, Yukunori Korogi	7
7	Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study 2018 ·PLoS ONE ·Yuki Konishi, Hikaru Hori, (unknown), Asuka Katsuki, Kiyokazu Atake, Ryohei Igata, (unknown), Hirotaka Tominaga, (unknown), (unknown), Reiji Yoshimura	13
8	Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics 2018 ·Translational Psychiatry ·Koichiro Sugimoto, Shingo Kakeda, Keita Watanabe, Asuka Katsuki, Issei Ueda, (unknown), Ryohei Igata, Osamu Abe, Reiji Yoshimura, Yukunori Korogi	45
9	Relationship between the hippocampal shape abnormality and serum cortisol levels in first-episode and drug-naïve major depressive disorder patients 2017 ·Depression and Anxiety ·(unknown), Shingo Kakeda, Keita Watanabe, Xiaodan Liu, Asuka Katsuki, (unknown), Hikaru Hori, Osamu Abe, Reiji Yoshimura, (unknown)	24
10	PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorder 2017 ·Translational Psychiatry ·Ryohei Igata, Asuka Katsuki, Shingo Kakeda, Keita Watanabe, (unknown), Hikaru Hori, Yuki Konishi, Kiyokazu Atake, (unknown), Yukunori Korogi, Reiji Yoshimura	15
11	Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report 2016 ·Neuropsychiatric Disease and Treatment ·Hikaru Hori, Ryohei Igata, Kiyokazu Atake, Asuka Katsuki, Jun Nakamura	3
12	Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone 2014 ·Neuropsychiatric Disease and Treatment ·Hikaru Hori, Kenji Yamada, (unknown), (unknown), Asuka Katsuki, Jun Nakamura, Reiji Yoshimura	27
13	Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients 2014 ·Annals of General Psychiatry ·Reiji Yoshimura, Taro Kishi, Hikaru Hori, Kiyokazu Atake, Asuka Katsuki, (unknown), Atsuko Ikenouchi, Nakao Iwata, Jun Nakamura	21
14	Plasma levels of interleukin‐6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder 2013 ·Human Psychopharmacology Clinical and Experimental ·Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi, Wakako Umene‐Nakano, Asuka Katsuki, Kiyokazu Atake, Jun Nakamura	54
15	Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients 2013 ·Journal of Psychiatric Research ·Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Atsuko Ikenouchi, Kiyokazu Atake, Jun Nakamura	32
16	Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD) 2012 ·CNS Spectrums ·Asuka Katsuki, Reiji Yoshimura, Taro Kishi, Hikaru Hori, Wakako Umene‐Nakano, Atsuko Ikenouchi, Kenji Hayashi, Kiyokazu Atake, Nakao Iwata, Jun Nakamura	36
17	No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients 2011 ·Human Psychopharmacology Clinical and Experimental ·Atsuko Ikenouchi, Reiji Yoshimura, Taro Kishi, Wakako Umene‐Nakano, Hikaru Hori, Asuka Katsuki, Kazuyoshi Saito, Nakao Iwata, Yoshiya Tanaka, Jun Nakamura	1
18	[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder]. 2010 ·PubMed ·Reiji Yoshimura, Atsuko Ikenouchi, Hikaru Hori, Wakako Umene‐Nakano, Kenji Hayashi, Asuka Katsuki, Nobuhisa Ueda, Jun Nakamura	9
19	Plasma levels of brain‐derived neurotrophic factor and interleukin‐6 in patients with dysthymic disorder: comparison with age‐ and sex‐matched major depressed patients and healthy controls 2010 ·Human Psychopharmacology Clinical and Experimental ·Reiji Yoshimura, Wakako Umene‐Nakano, Tsutomu Hoshuyama, (unknown), Hikaru Hori, Asuka Katsuki, Kenji Hayashi, Kiyokazu Atake, Jun Nakamura	27
20	No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations 2010 ·Human Psychopharmacology Clinical and Experimental ·Reiji Yoshimura, Wakako Umene‐Nakano, Nobuhisa Ueda, (unknown), Hikaru Hori, Asuka Katsuki, Kenji Hayashi, Kyoko Miyamoto, Yuki Kodama, Jun Nakamura	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact